Cephalon
North America, Pennsylvania, United States, Malvern
Description
Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the
Investor Profile
Cephalon has made 6 investments, with 0 in the past 12 months and 17% as lead.
Stage Focus
- Series Unknown (67%)
- Series E (17%)
- Corporate Round (17%)
Country Focus
- Japan (83%)
- United States (17%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
